Navigation

Soft tissue sarcoma - trabectedin

Trabectedin for the treatment of advanced soft tissue sarcoma

Status: History
Expected date of issue: February 2010
Referral date: July 2008
Process: STA
Topic area:
  • Cancer
 

NICE project team

Executive Lead: Gillian Leng
Technical Lead: Whitney Miller
Communications manager: Laura Gibson
Project manager: Jeremy Powell
Assessment Group / Evidence Review Group: School of Health & Related Research Sheffield (ScHARR)
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 26 November 2008
1st appraisal committee meeting: 02 June 2009
2nd appraisal committee meeting 04 August 2009
3rd appraisal committee meeting: 03 November 2009
Top


 

Consultees and commentators

Commentators Consultators (no right of appeal)

Manufacturers/ Sponsors

  • Pharma Mar (trabectedin)

 

Patient / Carer Groups

  • Rarer Cancers Forum
  • Sarcoma UK

 

Professional Groups

  • British Sarcoma Group
  • Cancer Research UK
  • Royal College of Nursing
  • Royal College of Pathologists
  • Royal College of Physicians – Medical Oncology Joint Special Committee
  • Royal College of Radiologists

 

Others

  • Department of Health
  • Welsh Assembly Government

General

  • Department of Health, Social Services and Public Safety for Northern Ireland
  • NHS Quality Improvement Scotland

 

Comparator Manufacturers

  • None

 

Relevant research groups

  • MRC Clinical Trials Unit

 

Evidence Review Group

  • School of Health & Related Research Sheffield (ScHARR)
  • National Institute for Health Research (NIHR) Health Technology Assessment Programme (HTA Programme)

 

Associated Guideline Groups

  • National Collaborating Centre for Cancer

 

Associated Public Health Groups

  • None

Top


 

Project history

Date  Update
11 December 2008 An extension to the timelines for submission of evidence in this appraisal has been granted on request of the marketing authorisation holder for Trabectedin to allow them to meet the full requirements of the STA process. The appraisal will now be discussed at a committee meeting on 2 June 2009 and the earliest anticipated guidance publication will be in October 2009.
7 October 2009 The manufacturer has submitted a Patient Access Scheme. This will be critiqued by the ERG and considered by the Committee on 3 November 2009

 

Top


 

Key documents

This page was last updated: 30 March 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.